IOVANCE BIOTHERAPEUTICS, INC. Number of Operating Segments
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. number of operating segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. number of operating segments for the quarter ending 2025-03-31 was 1.00 segment, a 0.00% change year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. number of operating segments for the quarter ending 2024-03-31 was 1.00 segment, a 0.00% change year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. number of operating segments for the quarter ending 2023-03-31 was 1.00 segment, a 0.00% change year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. number of operating segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- IOVANCE BIOTHERAPEUTICS, INC. number of operating segments for fiscal 2024 was 1.00 segment, a 0.00% change from fiscal 2023.
- IOVANCE BIOTHERAPEUTICS, INC. number of operating segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- IOVANCE BIOTHERAPEUTICS, INC. number of operating segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-24 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-27 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-28 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-02-28 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-24 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-02-25 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |